Hepcidin: The grail of iron metabolism;L'hepcidine: Le graal du métabolisme du fer?

Gastroenterologie Clinique et Biologique

Volumn 26, Issue 8-9, 2002, Pages 805-807

  Loreal O ^a   Brissot, P ^a  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEPCIDIN; PEPTIDE; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; GENE EXPRESSION; GENETICS; HEMOCHROMATOSIS; IRON METABOLISM; IRON OVERLOAD; SHORT SURVEY;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; DISEASE MODELS, ANIMAL; FERRITINS; HEMOCHROMATOSIS; HUMANS; INTESTINAL ABSORPTION; IRON; IRON OVERLOAD; TISSUE DISTRIBUTION;

EID: 0036698323     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (20)

1. Andrews NC. Disorders of iron metabolism. N Engl J Med 1999;341:1986-95.
2. Brissot P, Deugnier Y, Hemochromatosis In McIntyre, Benhamou J, Bircher J, Rizetto M, and Rodes J. Oxford Textbook of Clinical Hepatology, Oxford university Press, Oxford 1999, pp 1379-1391.
3. Schade AL et Caroline L. An iron binding component in human blood plasma. Science 1946;104:340-1.
4. Laufberger V. Sur la cristallisation de la ferritine. Bull Soc Chim Biol 1937;19:1575-82.
5. Brissot P, Guyader D, Loreal O, Laine F, Guillygomarc'h A, Moirand R, et al. Clinical aspects of hemochromatosis. Transfus Sci 2000;23: 193-200.
6. Simon M, Bourel M, Fauchet R, Genetet B. Association of HLA-A3 and HLA-B14 antigens with idiopathic haemochromatosis. Gut 1976:17:332-4.
7. Hider RC, Epemolu O, Singh S, Porter JB. Iron chelator design. Adv Exp Med Biol 1994;356:343-9.
8. Hentze MW, Caughman SW, Rouault TA, Barriocanal JG, Dancis A, Harford JB, et al. Identification of the iron-responsive element for the translational regulation of human ferritin mRNA. Science 1987;238: 1570-3.
9. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis [see comments]. Nat Genet 1996;13: 399-408.
10. Roy CN, Andrews NC. Recent advances in disorders of iron metabolism: mutations, mechanisms and modifiers. Hum Mol Genet 2001;10:2181-6.
11. Krause A, Neitz S, Magert HJ, Schulz A, Forssmann WG, Schulz-Knappe P, et al. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 2000;480: 147-50.
12. Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 2001;276: 7806-10.
13. Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 2001;276:7811-9.
14. Shike H, Lauth X, Westerman ME, Ostland VE, Carlberg JM, Van Olst JC, et al. Bass hepcidin is a novel antimicrobial peptide induced by bacterial challenge. Eur J Biochem 2002;269:2232-7.
15. Nicolas G, Bennoun M, Devaux I, Beaumont C, Grandchamp B, Kahn A, et al. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci U S A 2001;8780-5.
16. Nicolas G, Bennoun M, Porteu A, Mativet S, Beaumont C, Grandchamp B, et al. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci USA 2002;99: 4596-601.
17. Fleming RE, Sly WS. Hepcidin: a putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease. Proc Natl Acad Sci USA 2001;98:8160-2.
18. Weinstein DA, Roy CN, Fleming MD, Loda MF, Wolfsdorf JI, Andrews NC. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood First Edition Paper, prepublished on line, June 28, 2002; DOI10.1182. Blood 2002;4:1260.
19. Crichton R. Cellular iron uptake in mammals. In Inorganic biochemistry of iron metabolism. Second edition. Crichton R Ed. John Wiley and sons, Chichester, England, 2001, PP107-129.
20. Vorland LH, Ulvatne H, Andersen J, Haukland HH, Rekdal O, Svendsen JS, Gutteberg TJ. Antibacterial effects of lactoferricin B. Scand J Infect Dis 1999;31:179-84.